We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Smiths Group Plc | LSE:SMIN | London | Ordinary Share | GB00B1WY2338 | ORD 37.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
23.00 | 1.43% | 1,632.00 | 1,631.00 | 1,633.00 | 1,633.00 | 1,614.00 | 1,620.00 | 180,559 | 15:01:07 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Srch,det,nav,guid,aero Sys | 3.04B | 231M | 0.6613 | 24.63 | 5.69B |
Date | Subject | Author | Discuss |
---|---|---|---|
30/4/2018 07:38 | Smiths Group was a 'hold' for the Sunday Times' Inside the City column as chief executive Andy Reynolds Smith puts his shirt on full-year results from the engineering conglomerate in the autumn. The group is divided into five divisions: Smiths Medical, Smiths Detection, Smiths Interconnect and Flex-Tek. John Crane makes mechanical seals, couplings and filtration systems; Smiths Medical specialises in catheters, needles, systems for managing airway and temperature and emergency patient transport; Detection's products are sensors and systems for airports; Interconnect's are electronic connections, including cables and wireless; while Flex-Tek provides components to heat and move fluids and gases for the aerospace, medical, industrial, construction and domestic appliance markets. The first two contribute more than a quarter of groups revenues each, detection just under a quarter and the latter two around 10% apiece. Reynolds Smith was appointed with a growth remit and has been acquisitive in since joining in September 2015. The following year the shares surged 50%, but until the start of April had nothing to show. Interim results in March knocked disappointed the market as profit fell and missed analysts' forecasts. “The time is coming when he will be judged by the measurable impact of his actions — including the purchase of Morpho — rather than presentations,” | broadwood | |
28/3/2018 08:15 | Q&A from the recent conference call are well worth a listen. Was not surprised to see the share price recover somewhat on Friday. | mertles | |
26/3/2018 08:41 | Rather silent in here - good upwards movement over next few weeks IMO | ernestsyngen | |
12/1/2018 08:31 | Another neglected thread. Positive comment this morning on US tax implications. | broadwood | |
18/8/2017 16:56 | Industrial technology firm Smiths Group has spent most of the past year offloading different businesses but the rumour doing the rounds in the City today was it could soon change tack. On a quiet Friday, the hearsay was that the FTSE 100 company has its eye on Accelerate Diagnostics, a little-known US medical technology firm worth $1.3 billion (£1 billion) on Nasdaq. The Arizona-based company is working towards commercialising technology which helps to diagnose infectious diseases sooner. Its shares rose 5% yesterday against a falling market with trading volumes much higher than normal. Although Smiths’ name is in the frame for a potential tilt, larger US groups have a head-start on it, sources said. Frontrunners for Accelerate are said to be Thermo Fisher Scientific and Boston Scientific — both are much larger and have far more firepower than Smiths, whose operations range from energy services to specialist medical devices. It has sold several non-core business over the past year to buoy the balance sheet. After recent falls, Accelerate’s shares are now changing hands for only $23 a pop. Gossips said Accelerate and its directors, who control a large chunk of the company, would hold out for at least $35 a share. Smiths and Accelerate said they do not comment on speculation. Shares in Smiths were down 10.15p to 1553p, tracking UK stocks lower as investors digested the Barcelona terror attack and the increasingly chaotic nature of Donald Trump’s presidency. London Ev Standard | philanderer | |
01/8/2017 11:18 | SMIN 1,553 is starting to look like the only way is up in near future. | corlis | |
22/5/2017 14:50 | Poached and on gardening leave or blackhole? | linhur | |
19/5/2017 12:18 | Out on todays news. | philanderer | |
18/5/2017 10:51 | Airline association IATA has called on the European Commission and the US government to adopt additional airport safety measures rather than expand the current, controversial ban on personal electronic devices (PEDs) in the cabin of flights from Middle Eastern and North African countries. | philanderer | |
17/5/2017 01:01 | SMIN Smiths Group plc Smiths Detection Wins London Gatwick Airport Contract for CTX 9800 Hold Baggage Explosives Detection Systems CAMBRIDGE, England--(BUSINESS WIRE)-- - See more at: | philanderer | |
03/5/2017 17:36 | 3rd may Deutsche buy tp 1750p 3rd may JP Morgan overweight tp 1730p reiterations | philanderer | |
02/5/2017 10:00 | Streamlining continues , Microwave Telecoms booted. | philanderer | |
28/4/2017 21:19 | Ah , thanks martin :-) Nice dividend paid into the account today as well. | philanderer | |
28/4/2017 13:51 | Good find Phil. You were looking a bit lonely here, so I thought I would let you know that you are not alone!! I am very optimistic for #SMIN and we should see significant share price upside in the next 12 months IMO........I Hold. | martinthebrave | |
28/4/2017 13:22 | 2 Top FTSE 100 stocks for explosive earnings growth | philanderer | |
10/4/2017 16:27 | Goldman raises tp from 1800p to 1850p ... Buy | philanderer | |
08/4/2017 07:24 | Smiths Group announces completion of acquisition of Morpho Detection | philanderer | |
06/4/2017 09:58 | 6th april HSBC buy tp 1900p up from 1700p | philanderer | |
05/4/2017 09:06 | xd tomorrow morning for the 13.55p dividend | philanderer | |
02/4/2017 09:54 | Smiths Group: Market Is Undervaluing Improvements Even At 52-Week Highs | philanderer | |
30/3/2017 14:32 | 30th march RBC outperform tp 1750p up from 1700p | philanderer | |
28/3/2017 20:44 | 28th march Goldmans buy tp 1800p up from 1740p | philanderer | |
27/3/2017 10:06 | 27th march JP Morgan overweight tp 1730p up from 1612p | philanderer |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions